Brand Names: Tildiem, Dipen, Cardil
Diltiazem (a Class IV antiarrhythmic agent) belongs to the calcium channel blocker (CCB) class. Along with verapamil, these are the primary agents within this class that exert direct myocardial effects. This distinguishes them from other calcium channel blockers, which predominantly exhibit peripheral vasodilatory activity. Diltiazem can be administered both orally and intravenously. It exerts a more pronounced effect on the sinoatrial (SA) node, inducing sinus bradycardia, and on the atrioventricular (AV) node, resulting in a reduction of conduction velocity. [
Indications
- Oral formulations may be indicated for the prevention of supraventricular tachycardias.
- Diltiazem can be administered for rate control in patients presenting with atrial fibrillation or atrial flutter accompanied by a rapid ventricular response. However, the drug does not possess cardioversion properties and cannot restore normal sinus rhythm. Similarly, verapamil can be administered for rate control in patients with atrial fibrillation or atrial flutter and rapid ventricular rates, without exerting any effect on active cardioversion or the restoration of normal sinus rhythm.
Adverse Effects & Contraindications
- Administration is strictly contraindicated in patients with heart failure.
- Hypotension, bradycardia, atrioventricular (AV) block, and asystole may occur, particularly during concomitant administration with beta-blockers